Kansas State University is working with a Korean company using a new technique to develop a vaccine to counter African Swine Fever.
The project is on a three-year research and development schedule.
The university’s partner is MEDIAN Diagnostics Inc., or MDx, a veterinary medicine company based in South Korea.
The technology we are utilizing is based on a novel adenovirus backbone — developed from human adenovirus serotype 6 — that can amplify a transgene up to 10,000 copies in the infected cell without producing infectious viruses," said Waithaka Mwangi, professor of diagnostic medicine and pathobiology in the university's College of Veterinary Medicine.
